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NEW TRENDS IN DRUG RESEARCH:
MARIHUANA - A CASE IN POINT*
by
Leo E. Hollister**

T

HE evergrowing social use of cannabis derivatives in the Western
world has once again caused concern about its consequences. Following
the brief interest in clinical research initiated by the La Guardia Commission over twenty years ago,' few subsequent studies of the effects of marihuana in man have been done.2 Recently, such studies have been resumed,
using newly available 1-A'-trans-tetrahydrocannabinol (A'-THC or
THC), or extracts of marihuana calibrated for THC content.
I.

LEGAL CONSIDERATIONS IN MARIHUANA RESEARCH

Although some legal hobbles bothered researchers two years ago, they
are not especially troublesome now. When I began my work, the state of
California had a statute allowing the state division of narcotics to dispose
of marihuana for purposes of research or instruction only to the heads of
schools of medicine, pharmacology, and criminology which had been approved by the attorney general.' Thus, even though I met federal requirements,' I was apparently ineligible under the state qualifications. The Federal Bureau of Narcotics liberally construed the federal requirements. As
long as I did my work at the Veterans Administration Hospital, it was
considered to be federal territory and therefore beyond the jurisdiction of
the state. Fortunately, no one has challenged this interpretation.
The channels for doing research on drugs of dependence are reasonably
clear as far as federal requirements are concerned Under the informal
administrative procedure of the National Institute of Mental Health, the
experimental protocol is submitted to the Drug Dependence Section of the
Institute, which is also authorized to supply materials as requested. If the
protocol is approved by the Institute's scientific review committee, the
* This Article is based on a lecture delivered to the Short Course on Drug Abuse at Southern
Methodist University, April 8, 1970.
** B.S., M.D., University of Cincinnati. Medical Investigator, Veterans Administration Hospital,
Palo Alto, California; Associate Professor of Medicine, Stanford University School of Medicine.
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(1944).
'Most of these studies, quite possibly because of legal difficulties in obtaining natural marihuana
preparations, employed the synthetic tetrahydrocannabinol homolog, synhexyl. This material was
used for several medical purposes. See, e.g., Himmelsbach, Treatment of the Morphine-Abstinence
Syndrome with a Synthetic Cannabis-Like Compound, 37 S. MED. J. 26 (1944); Parker & Wrigley,
Synthetic Cannabis Preparations in Psychiatry: (I) Synhexyl, 96 J. MENTAL ScI. 276 (1950);
Stockings, A New Euphoriant for Depressive Mental States, 1947 BRIT. MED. J. 918; Thompson
& Proctor, The Use of Pyrahexyl in the Treatment of Alcoholic and Drug Withdrawal Conditions,
14 N.C. MED. J. 520 (1953).
'CAL.
HEALTH & SAFETY CODE § 11655 (West 1964), as amended, § 11655 (West Supp.
1969).
4
INT. REV. CODE Of 1954, §§ 4751, 4753.
STUDIES

526 C.F.R. §§ 152.66-.71 (1970).
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Food and Drug Administration is notified so that a separate application
for investigation of a new drug need not be filed. As most research is
based in some institution, it is implicit that additional review has been
done by institutional research committees, as well as committees on human
studies, if humans are involved. Materials are provided the investigator in
amounts required to do his proposed experiment. Under federal regulations,
he must report on the progress of the experiment at least annually, and
keep records of the disposition of the materials which have been provided.!
Unfortunately, the state may become involved. California requires an
investigator to submit his proposal to a state review board of mixed disciplines to determine whether or not the research should be continued.'
Besides being a duplication of effort, this could lead to the contretemps in
which federal approval was given and state approval withheld. Obviously,
states should not pass laws controlling research with drugs of dependence
without full awareness of federal regulations. Such a principle might also
be applied to laws regulating the possession, distribution, and sale of drugs,
as well as the implementation of treatment programs.
II.

PROBLEMS WITH MATERIALS AND DOSAGE

The older clinical studies were far less quantitative than would ordinarily be demanded of pharmacological studies. These older inquiries usually expressed doses as so many milliliters of cannabis extract produced in

some standard fashion, or as the equivalent of so many milligrams of cannabis material. Unless the components of such materials are known, such
bases for dosages are extremely uncertain.
My associates and I obtained from the Bureau of Narcotics two samples
of marihuana. One was a potent material that was grown in Turkey and
labeled "hashish." Our assay indicated that its content of A1-THC was
slightly more than 2%. In addition, it contained amounts of other cannabinoids: cannabidiol, the precursor of THC, and cannabinol, the product
of THC decomposition. The same agency provided us with a "brick" of
marihuana which had been seized and held for evidence. This sample contained no detectable tetrahydrocannabinol, a good quantity of cannabinol,
and an unidentified material which may have been cannabidiolic acid or its
ester. The difficulties in identifying some of the components arise because
adequate standards of marihuana constituents are difficult to obtain. Even
a sample of the United Nations Reference Standard of cannabis obtained
with considerable difficulty from the U.S. Department of Justice contained
no THC, despite having some cannabinol and cannabidiol. Enormous variations in content of active materials exist in any natural product, and certainly cannabis is no exception.
Obviously, before clinical experiments with extracts of the natural product, or marihuana itself, may be performed, careful quantitative assays
for THC content must be done and doses in terms of equivalence of THC
61d.

'CAL.
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specified. While it is still argued whether or not THC is the sole active
material in cannabis, it seems reasonably certain that it accounts for the
major amount of activity, and thus qualifies as a reasonable basis for dosage.
The extraction of cannabis and the quantification of THC content by
gas-liquid chromatography is not especially difficult, because the extracts
hold chemical stability for considerable periods of time when kept under
refrigeration. However, the greatest objection is the noxious taste. Fortunately, almost complete extraction of the cannabinoids still leaves a residue which can then be re-extracted to provide a foul-tasting material
which can be used as a placebo.
Giving oral doses of extracts, or THC itself, is advantageous in that the
components of the doses are known with some precision. However, the
amount absorbed in an active form is uncertain. The smoking of cannabis
which has been quantified for THC content raises even more questions:
(1) How much of the putative dose is absorbed? (2) What is the difference in potency between materials absorbed directly into the blood
through the lungs, as opposed to gastrointestinal absorption and a pass
through the liver where it could be metabolized in part before reaching
the brain? (3) Does smoking change the activity of cannabis, forming
new or additional active materials? (4) Can one rely on reports of "getting
high" from smoking to use as an end-point in dosage? In regard to the
latter question, I would have some doubts based on conflicting reports
from volunteer smokers of our THC-free marihuana. When three subjects smoked in a group, all reported some degree of activity, but when
one sophisticated user smoked alone, he reported none. The latter observation was consistent with the failure of the material to produce effects in
another subject when a sizable amount of extract of the material was
given orally.
III.

STUDIES USING SYNTHETIC

A'-THC

ORALLY

Researchers at the Addiction Research Center of the U.S. Public Health
Service Hospital, Lexington, Kentucky, and ourselves have both published on the effects in man of oral doses of synthetic THC.8 The Lexington group employed a dosage of 10 to 30 milligrams, or 120 to 480 micrograms per kilogram. We used doses of 30 to 70 milligrams, or 341 to 946
micrograms per kilogram. Thus, the two studies were complimentary in exploring a wide range of dosage. It should be emphasized that this range is
still more than the effective dose received from smoking an ordinary marihuana cigarette. However, it is not greater than the amount one might
get from smoking several cigarettes of reasonable quality, or from smoking the stronger preparation, hashish.
Briefly stated, the results are as follows:
(a) Physiological changes. No changes in pupil size, respiratory rate, deep
' Hollister, Richards & Gillespie, Comparison of Teirahydrocannabinol and Synhexyl in Man,
9 CLIN. PHARMACOL. THER. 783 (1969); Isbell, Gorodetzsky, Jasinski, Claussen, Spulak & Korte,
5
Effects of (-)A -Trans-Tetrahydrocannabinolin Man, 11 PSYCHOPHARMACOLOGIA 184 (1967).
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tendon reflexes, or oral temperature were observed. Pulse rate rose constantly. Systolic and diastolic blood pressures tended to fall; orthostatic
hypotension may have accounted for two faints. Conjunctival injection
paralleled the clinical course. Finger ergograph tracings revealed the development of muscular weakness which was progressive.
(b) Perceptual and psychic changes. Euphoria was a predominant and
persistent symptom, followed by the development of sleepiness. Time sense
was altered, hearing less discriminant, vision apparently sharper with many
visual distortions. Depersonalization, difficulty in concentrating and thinking, and dream-like states were prominent. Many of these symptoms were
similar to those produced by psychotomimetics of the LSD-mescalinepsilocybin class. On self-reporting scales, the subjects initially became
more friendly, but less so with the passage of time; they became less aggressive, especially late in the course; they began to get sleepy, especially
after three hours; and they became persistently less clear-thinking, euphoric, and dizzy.
(c) Psychometric tests. Repetitive psychometric measures of arithmetic
ability (Number Facility: NF) or drawing freehand (Flexibility of Closure: FC) showed differing kinds of impairment. The NF test, a familiar
and simple task, showed a slowing of performance against time, with maintained accuracy. The FC test, less familiar and more difficult, showed reduced accuracy with no slowing of performance, probably indicating some
loss of finer judgment.
(d) Biochemical determinations. Plasma-free, fatty acids remained un-

changed, unlike the case with drugs of the LSD-type. Blood glucose values
were also unchanged. Both creatinine and phosphorus clearance were temporarily decreased. This is a phenomenon which has been observed with
LSD.
We compared A-THC with synhexyl, a synthetic THC-like material.
The latter has been studied rather extensively in the past for possible clinical utility. On the whole, the changes reported above were also produced
by synhexyl, but the A-THC was three times more potent than the synhexyl. The latter drug was slower in initial action by about one hour, but
longer-lasting in equivalent doses.
The Lexington group has compared the effect of taking THC orally
with the effect of smoking cigarettes containing known quantities of THC.
They estimate that potency is increased approximately three-fold by
smoking as compared with taking the same material by mouth. As might
be expected, effects arise much quicker, but are of briefer duration, when
the material is smoked. They have compared the effects of smoked THC
(75 to 225 micrograms per kilogram) with those of LSD given intramuscularly in doses of 0.5 to 1.5 micrograms per kilogram.' Subjective
effects between the two drugs were not readily distinguishable, but objective differences were marked: LSD increased body temperature, systolic and
diastolic blood pressure, deep tendon reflexes, and dilated the pupils, while
' Isbell & Jasinski, A Comparison of LSD-25 with (-)A-Trans-Terahydrocannabinol (THC)
PSYCHOPHARMACOLOGIA 115 (1969).

and Attempted Cross Tolerance Between LSD and THC, 14

1970]

DRUG RESEARCH

THC had none of these effects. We made a retrospective comparison of the
effects of LSD and THC taken orally and came to similar conclusions regarding the objective differences.' Subjectively, we thought that THC produced less total impairment with more euphoria and dreamlike states than
LSD at comparable doses, and that, unlike the latter drug, sedation was a
prominent feature with THC as most subjects fell asleep. In general, we
have seen less psychotomimetic effects than the Lexington group. They
have used patients formerly addicted to narcotics as subjects, while we have
used primarily graduate students. This may explain the different reports of
subjective effects.
IV.

STUDIES WITH QUANTIFIED

MARIHUANA

EXTRACTS

ORALLY

We have completed additional experiments using extracts of marihuana,
gauging doses on the basis of THC content. We have used doses ranging
from 5 to 60 milligrams, as well as making comparisons between these and
the placebo extract. Even with the smaller doses, all subjects had appreciable clinical effects as compared with placebo. With the larger doses,
psychotomimetic effects were observed. Generally, the effects produced by
these extracts were comparable to those which would have been produced

by similar doses of synthetic THC. None of these studies has yet been
published, but the results of some are known.
A number of psychological tests have been done. The most conspicuous
result has been the fact that even relatively small doses of marihuana disrupt short-term memory, such as used in keeping track of a task. Longterm memory is not impaired. The same division between tests that are
impaired and those which are not was seen with regard to a number of
other such psychological functions. But with most sizable doses at any
given time, subjects would be likely to show impairment of a considerable
number of intellectual and motor functions. We have also studied the effects of marihuana on appetite, hunger, and food consumption, comparing
it to alcohol, dextroamphetamine, and placebo. Although marihuana is
reputed to stimulate appetite, it did so under experimental conditions only
some of the time; i.e., seven of twelve subjects consumed more food with
more gusto after marihuana than after the other comparison treatments.
We still don't know the extent to which these differences represent variations between subjects, or variations within subjects over repeated testing.
A group at the University of Utah has also made use of marihuana extracts for clinical studies. 1 They, too, have been impressed with the disruptive effects of marihuana on sequential thought, suggesting impairment
of rapid decision-making and short-term memory. As have others, they
have noted a great variability in performance during marihuana intoxication, which may be related to the fact that subjects go "in-and-out"the effects seeming to come and go in cycles and waves.
0

ON DRUG ABUSE, DRUGS AND YOUTH 208-11 (1969).
" Clark & Nakashima, Experimental Studies of Marihuana, 125 AM. J. PSYCHIATRY 379 (1968).

1 RUTGERS SYMPOSIUM
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STUDIES WITH SMOKED MARIHUANA

As marihuana is more commonly smoked than taken orally, some investigators feel that proper studies can be done only by utilizing this particular method of administration. The major argument is that native marihuana may include other active materials which are not found in synthetic
THC or extracts, or that the process of combustion may create new active
materials. No proof for either assertion is available. One great disadvantage
of this method of administration is that the dose, even when the amount
in the cigarette is known, is impossible to judge, as variations in technique
of smoking may create tremendous variations in delivery of the dose.
The first study provided marihuana in cigarettes with the putative doses
being 4.5 and 18 milligrams, which were compared with a placebo smoke."
Naive smokers experienced few subjective effects, although they showed
an increased heart rate and conjunctival injection. Experienced smokers of
marihuana reported a typical "high," which was not elaborated upon.
Performance on the digit-symbol substitution test and the pursuit rotor
test was impaired, but curiously, the continuous performance test, which is
usually more sensitive, was unchanged. No changes in blood sugar were
found. In general, the effects of the drug smoked in this fashion were found
to be relatively mild and innocuous, leading the investigators to take a
sanguine view of the social use of the drug.
Using a driving simulator, another study tested driving skill in untreated subjects who smoked marihuana cigarettes until "high" and consumed large doses of alcohol."3 Under marihuana conditions, speedometer
errors were increased, suggesting that the subjects did not monitor the
speedometer as carefully as they might have normally. Driving was otherwise little impaired. As might have been expected, marked impairment
was observed from the high doses of alcohol. Such highly controversial
findings have elicited criticism directed at the fact that the doses of the
two drugs were disproportionate, that a dose-response curve was not obtained, and that simulated driving might not be an adequate model for
real life.14 My own objections are, that the study could have scarcely been
better designed to provide a miniscule dose of marihuana or to miss the
effects when testing. Smoking to a "high" is imprecise enough, but if it
really took thirty minutes to smoke the cigarette (as the paper states), then
it was scarcely smoked at all. Proper smoking technique usually consumes
a cigarette within five to ten minutes. The first study mentioned, which
used relatively small doses of marihuana, but still probably larger than used
in the simulated driving study, found that most effects of the drug had
dissipated by the end of one hour. This was precisely the time the subjects
were tested for their driving ability. Although the authors were careful to
refrain from stating that marihuana did not affect the ability to drive a
" Weil, Zinberg & Nelsen, Clinical and Psychological Effects of Marihuana in Man, 162 Sc,ENCE 1234 (1968).
13 Crancer, Dille, Delay, Wallace & Haykin, Comparison of the Effects of Marihuana and Al-

cohol on Simulated Driving Performance, 164 ScrENcE 851 (1969).
14 Kalant, Marihuana and Simulated Driving, 166 SCIENCE 640 (1969).

1970]

DRUG RESEARCH

car, it is unfortunate that many lawyers and courts may draw this conclusion. Sometimes it is better not to be so scientific. Since our first experiments, we have simply asked subjects when they were "high": "Do you
think you could drive a car now?" Without exception the answer has been,
"No!"
VI. SOME POSSIBLE IMPLICATIONS FOR THE LAW

The social use of marihuana under most circumstances is based upon
relatively weak doses of THC, and is consequently a mild intoxication.
In part, this is due to the very low THC content of much of the marihuana available for social use, as well as to the intrinsic difficulty in administering a dose efficiently by means of smoking. Consequently, generalizations about the social desirability of the drug on such limited experience
should be cautiously made. The higher doses of drug given orally in the
two studies thus far completed indicate that the full range of psychotomimetic effects and their complications can be expected when stronger
materials become more generally available."' The present comparison of
marihuana with alcohol is based on a dose similar to beer with a 2% alcoholic content, rather than gin with a 43% alcoholic content.
From the legal point of view, it may be desirable to distinguish several
different forms of marihuana, rather than to lump cannabis derivatives
together. To return to the analogy with alcoholic beverages, the degree of
potency of the various products may be considered. Native marihuana
ranges in THC content from very small amounts, such as 0.05%, to somewhere between 1.0 and 1.5%. Just as there are vintages wines, so there are
vintage grasses, with some species and some growing areas producing higher
yields. Nonetheless, native, American-grown grass might be regarded as
relatively mild. When it is in the possession of, and being used by, untold
millions of our citizens, it may be most realistic at least to eliminate the
penalties for possession of amounts of this material appropriate for personal use. I would judge that amounts less than one kilogram of dried natural material could be presumed for personal use, just as would possession of
three cartons of cigarettes. We would, in effect, be encouraging the equivalent of beer-drinking. Such a change could hardly make matters any worse
than they now are.
By the same token, we should like to discourage the use of more potent
material. Imported marihuana plant materials,"6 resin," or extracts ' might
be included in a separate category. Penalties might still be retained for their
"Despite the relative weakness of most available marihuana preparations, an increasing number
of reports of adverse reactions appear in the medical literature. However, these represent only a
small fraction of the total number. See, e.g., Baker & Lucas, Some Hospital Admissions Associated
with Cannabis, 1969 THE LANCET 148; Leonard, Cannabis: A Short Review of its Effects and
Possible Dangers of its Use, 64 BRIT. J. ADDICTION 121 (1969); Perna, Psychotogenic Effect of
Marihuana, 209 J.A.M.A. 1085 (1969); Talbott & Teague, Marihuana Psychosis: Acute Toxic
Psychosis Associated with the Use of Cannabis Derivatives, 210 J.A.M.A. 299 (1969).
" Imported plant materials from Mexico or Vietnam may be much more potent in THC than
those from domestic sources.
" This would include hashish, which is usually prepared outside the United States.
sI have examined one extract that had 70% THC content. This is relatively simple to make.
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possession, and such penalties might be similar to those deemed appropriate
for hallucinogenic drugs.
In still another category, synthetic analogs of THC or their precursors
might be included. Although the synthesis of THC is not at all easy at the
moment (this has slowed down research with this material), it may be
feasible for illicit laboratories to undertake this business in the next few
years. The cost will remain high, and, therefore, synthetic THC will have
only a limited market, but we should probably still want to discourage
use of synthetics by some appropriate penalties.
In short, in terms of legal definitions, a blanket grouping together of all
cannabis preparations and synthetics of THC is less suitable than making
distinctions based on the potency of the materials and the severity of their
intoxicating effects. Precedents for such differential labeling of intoxicants
can be found in some of our licensing procedures regarding beer and
wines, as opposed to spiritous liquors, or on the alcohol tax structures of
other countries (for example, Finland) where an attempt is being made by
using markedly different levels of taxation to alter drinking habits from
spiritous liquors to beer. The law can be used to implement social goals if
we can define what these should be.
As the law has shown remarkable responsivity to social needs in the recent past,' it seems ridiculous that it should still be a matter of great concern that the law may impede research on drugs of dependence. If one
matter can be agreed upon in this whole controversial field, it is that we
need more research. Yet many sober individuals are greatly concerned that
present laws at the state level and even the legislation presently under consideration by the Congress" will seriously impair research. Surely no law
should be passed which affects research on drugs of dependence without
ample consultation with those who are actively involved in this area.
Seldom has it been more necessary that legislators, law enforcement people,
and courts work closely with medical and social scientists to come to grips
with a common problem.

" An excellent example of such responsivity is the vast changes in state abortion laws in the
past several years.
20S. 3246, 91st Cong., 1st Sess. (1969).
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